Production of recombinant adeno-associated viral vectors and use in in vitro and in vivo administration
- PMID: 21971848
- PMCID: PMC3209619
- DOI: 10.1002/0471142301.ns0417s57
Production of recombinant adeno-associated viral vectors and use in in vitro and in vivo administration
Abstract
Adeno-associated virus is a nonpathogenic human virus that has been developed into a gene-delivery vector due to its high efficiency of infection for many different cell types and its ability to persist and lead to long-term gene expression. This unit describes efficient methods to generate high-titer, research-grade, adenovirus-free recombinant single-stranded and self-complementary adeno-associated virus in various serotypes, along with methods to quantify the viral vectors. Two detailed methods are provided for viral vector delivery into the rodent brain and spinal cord, and for histological detection of transgene expression of GFP.
Figures
References
-
- Boissy R, Astell CR. An Escherichia coli recBCsbcBrecF host permits the deletion-resistant propagation of plasmid clones containing the 5′ terminal palindrome of minute virus of mice. Gene. 1985;35:179–185. - PubMed
-
- Burger C, Gorbatyuk OS, Velardo MJ, Peden CS, Williams P, Zolotukhin S, Reier PJ, Mandel RJ, Muzyczka N. Recombinant AAV viral vectors pseudotyped with viral capsids from serotypes 1, 2, and 5 display differential efficiency and cell tropism after delivery to different regions of the central nervous system. Mol Ther. 2004;10:302–317. - PubMed
-
- Cukor G, Blacklow NR, et al. Biology of adeno-associated virus. In: Berns KI, editor. The Parvoviruses. Plenum; New York: 1984. pp. 33–66.
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
